Evidence map›Paper›PMID 33498980›Full record

ArticleBiomedicines2021

Liraglutide-Induced Hepatotoxicity.

Yaakov Maor, David Ergaz, Stephen D H Malnick, Ehud Melzer, Manuela G Neuman

Abstract read
In one paragraph

Article in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Liraglutide and Liver Injury: Rare Case Report with Literature Review.Endocrine, metabolic & immune disorders drug targets · 2024
    Review
  6. Review
  7. Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different.International journal of molecular sciences · 2022
    Review
  8. Review
  9. Review
  10. An Exceedingly Rare Case of Liraglutide-Induced Liver Injury.Case reports in gastrointestinal medicine · 2021
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yaakov MaorKaplan Medical Center, Institute of Gastroenterology and Hepatology, Hebrew University Medical School of Jerusalem, Rehovot 71600, Israel.
David ErgazInternal Medicine Day-Care Kaplan Medical Center, Hebrew University Medical School of Jerusalem, Rehovot 71600, Israel.
Stephen D H MalnickKaplan Medical Center, Department of Medicine C, Rehovot 71600, Israel.
Ehud MelzerKaplan Medical Center, Institute of Gastroenterology and Hepatology, Hebrew University Medical School of Jerusalem, Rehovot 71600, Israel.
Manuela G NeumanIn Vitro Drug Safety and Biotechnology and Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON M5G 1L5, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 52-year-old woman with a BMI of 31.2 kg/m

Indexed as

drug-induced liver injuryliraglutide-induced immune hepatitislymphocyte toxicity assaypersonalized medicine

Identifiers

PMID33498980
PMCPMC7911918

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.